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Summary
 Background Radiation causes serious damage to the spinal cord and several agents are used 
for protection.
 Aim The aim of this study was to assess the neuro-radioprotective effect of melatonin 
on the cervical spinal cord.
 Materials/Methods A sample of 32 male adult Wistar albino rats weighing 200–250g was used. They 
were divided into four groups of eight animals: control, melatonin (30mg/kg 
per day) and radiation (single Gamma dose of 10Gy) groups and the group that 
received radiation plus melatonin. After 72 hours, all rats were sacriﬁ ced for his-
topathological analysis of malondialdehyde, glutathione and protein biochemi-
cals.
 Results Malondialdehyde and protein levels were decreased after melatonin treatment 
while glutathione level was increased (p<0.005). Overall histopathological chang-
es were markedly decreased after melatonin treatment in comparison to radia-
tion group (p<0.05).
 Conclusions In conclusion melatonin may be useful in preventing the spinal cord against ra-
diation toxicity due to its potential for free oxygen radical scavenging.
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BACKGROUND
The central nervous system is irradiated in many 
malignant pathologic conditions and deleterious 
effects of gamma irradiation are common in nerv-
ous and normal supporting tissues. The extent 
of these side effects depends upon the radiation 
dose frequency and the size of the exposed area 
[1,2]. The most threatening types of damage in 
irradiated spinal cord tissue are necrosis, gliosis 
and white matter changes. Gamma irradiation 
dominantly conducts tissue damage through free 
radical production. Investigations have shown that 
oxygen free radicals may cause lipid peroxidation 
and oxidative stress. Melatonin, a secretory prod-
uct of the pineal gland in the brain, was report-
ed to be an effective agent in the regulation of a 
number of physiological and pathological proc-
esses [3]. Melatonin has been shown to scavenge 
hydroxyl and peroxyl radicals and peroxy nitrite 
anions; nitric oxide, singlet oxygen and lipid per-
oxyl radicals, and it acts as on antioxidant [2–4]. 
Melatonin has also been shown to stimulate en-
zymes involved in metabolizing reactive oxygen 
intermediates by further increasing its ability to 
protect against free radicals [2–7].
AIM
In this study spinal cord damage after total body 
irradiation in rats was investigated as well as the re-
sponse of MDA, GSH and protein to such injury.
MATERIALS AND METHODS
The experiment was performed on 24 male adult 
Wistar albino rats weighing 200g to 250g. The rats 
were randomly divided each into four groups of 
eight animals. Group I was the control group, 
group II only received whole body radiation with 
a single dose of 10Gy gamma rays, group III was 
only injected with melatonin in a daily dose of 
30mg/kg, and group IV received both melaton-
in and radiation simultaneously. Rats were irra-
diated with a Cobalt–60 teletherapy unit and af-
ter 72h they were autopsied under ketamine and 
chlorpromazine decapitation.
Histopathological investigation
The tissue samples after normal and routine 
processing were embedded in parafﬁ n wax. Slices 
4μm thick were prepared and stained with hema-
toxylin and eosin (H&E) for evaluation with light 
microscopy. Morphological evaluation of the spi-
nal cord tissue was done blindly. Histopathological 
damage was scored on a scale of 0–3 (0 – none, 
1 – mild, 2 – moderate, 3 – severe).
Biochemical survey
Malondialdehyde (MDA) levels of tissue and glu-
tathione (GSH) activity were estimated. Lipid 
peroxidation was determined according to the 
thiobarbitionic acid (TBA) method. Glutathione 
content was determined as explained by Kuo and 
Hook (1982). Total protein concentration was 
estimated by the Bradford method (Bradford 
1979).
RESULTS
The differences in mean GSH values of the con-
trol, radiation and radiation plus melatonin 
groups were found to be statistically signiﬁ cant 
(p<0.05). The same analysis for MDA showed 
signiﬁ cant differences (p<0.05) and for chang-
es in protein concentration it was again signiﬁ -
cant (p<0.05) (Figure 1).
Histopathologically, mean and quantitative sum-
mation values (or total effect) of different vari-
ables in terms of inﬂ ammation, mono-nuclear 
inﬁ ltration, congestion, necrosis, vesiculation, 
demyelination and thrombosis are shown in 
Table 1. There were statistically signiﬁ cant dif-
ferences in total effects of radiation and control 
groups (p<0.05). The differences between control 
and radiation plus melatonin groups were signiﬁ -
cant for inﬂ ammation, mono-nuclear inﬁ ltration, 
congestion, necrosis, vesiculation, and demyeli-
nation (p<0.05). Statistical differences were not 
signiﬁ cant for inﬂ ammation and mono-nuclear 
inﬁ ltration between radiation and radiation plus 
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Figure 1. Comparison of mean GSH, MDA and protein concentrations 
of the groups vs controls.
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melatonin groups (p>0.05). However, t-test re-
sults showed a signiﬁ cant difference for demy-
elination and necrosis (p<0.05). Data of corre-
lation coefﬁ cients (R’s) from Spearman analysis 
are shown in Table 2 in addition to their p-val-
ues. An inverse correlation was found between 
histopathologic data and change in GSH concen-
tration. However, correlation coefﬁ cients were 
positive for MDA and protein concentrations 
(Table 2). In other words, an increase in patho-
logic changes secondary to irradiation was asso-
ciated with a decrease in GSH enzyme but an in-
crease in MDA and proteins.
Qualitatively, irradiation signiﬁ cantly caused an 
inﬂ ammatory condition including vasodilatation, 
increase in vascular density, necrosis associated 
with neuronal degeneration and gitter cell for-
mation (Figure 2). Melatonin may be an efﬁ cient 
protective agent in all pathologic conditions ex-
cept for vesiculation.
DISCUSSION
Radioprotectors have a number of potential ap-
plications in radiotherapy. Some substances al-
though they do not directly affect the radiosen-
sitivity of cells nevertheless may protect whole 
animals because they cause vasoconstriction or 
Groups
Histopathological values: mean ±standard error (95% confi dence interval)
Total eff ect
Infl ammation Mononuclear infi ltration Congestion Necrosis Vesiculation Demyelination Thrombosis
Control 0.33±0.21 (0.54)
0.33±0.21 
(0.54)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00) 0.66±.21
Radiation 2.50±0.22 (0.57)
2.67±0.21 
(0.54)
1.67±0.21 
(0.54)
2.17±0.17 
(0.43)
1.34±0.21 
(0.54)
3.00±0.00 
(0.00)
0.83±0.17 
(0.43) 13.35±.22
Melatonin 0.00±0.00 (0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00)
0.00±0.00 
(0.00) 0.00±.00
Radiation
+ Melatonin
1.83±0.17 
(0.43)
1.67±0.34 
(0.85)
1.00±0.00 
(0.00)
0.17±0.17 
(0.43)
2.00±0.00 
(0.00)
1.33±0.21 
(0.54)
0.00±0.00 
(0.00) 8.00±.34
Table1. Histopathological values in all groups.
Enzyme
Total pathologic eff ect
Correlation 
coeffi  cients (R’s) P-values
GSH  –0.94  0.83
MDA  0.94  0.057
Protein  0.94  0.057
Table 2. Correlation coeffi  cients between histopathologic and 
enzymatic changes after irradiation.
Figure 2. Some of the white matter changes are shown: (A) 
Necrotic neural cells, chromatolysis, demyelination and vascular 
changes are demonstrated in the irradiated group (H&E, ×100). 
(B) Changes in neural cells and in the number of vessels are shown 
in the melatonin treated group (H&E, ×100). Ne – Necrosis; Cr – 
chromatolysis; De – Demylination; ve – vessel; G – Gitter cell.
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in some way upset the normal process of metab-
olism to such an extent that the oxygen concen-
tration in critical organs is reduced. There is 
another group of radioprotectors, such as ami-
fostine, that scavenge free radicals generated by 
ionizing radiation [8].
Radiation myelopathy is known as one of the most 
important complications of radiation in radio-
therapy of patients and recent studies have dem-
onstrated dose and time dependent radiation 
effects. Destructive changes of the white matter in-
frastructure constitute the main histopathological 
aspect [9,10]. Dose response curves for treatment 
of malignancies profoundly show a strict margin 
between virtual 100% tumoricidal dose and neu-
rotoxicity occurrence in spinal cord as a normal 
tissue [11]. Free radical damage, particularly ac-
tivated oxygen derivatives, was reported to be the 
signiﬁ cant mechanism in cell injury. Cell oedema 
(reversible injuries) and cell necrosis (irreversible 
ones) are caused by oxygen free radicals [12].
Melatonin synthesized by the pineal gland is 
known to play a signiﬁ cant role in the regulation 
of many physiological events [13]. It also has an 
antioxidant effect by scavenging hydroxyl and 
peroxyl radicals and peroxy-nitrite anions [14]. 
The in vitro investigation of Tan et al., 1993, was 
the ﬁ rst report of melatonin protective effects to 
scavenge the ·OH radicals generated when hy-
drogen peroxide was exposed to ultraviolet light 
[15]. Investigations on blood lymphocytes also 
showed a reduction in the incidence of abnormal 
cells with genetic damage. Irradiated lymphocytes 
exhibited signiﬁ cant reduction in incidence of 
chromosomal aberrations and micronuclei for-
mation after the administration of melatonin 
(60–65%) [16]. Satisfactory results of in vitro in-
vestigations led to extensive in vivo studies [17]. 
The data from Mehmet et al., 2003, suggest that 
pretreatment with melatonin signiﬁ cantly lowers 
the extent of oxidative damage as determined by 
malondialdehyde levels, as well as the activities 
of superoxide dismutase and gluthatione perox-
idase in the liver tissue of rats subjected to whole 
body 6Gy gamma radiation [18].
Our results revealed that the GSH level was de-
creased following irradiation but in the presence 
of melatonin it was increased in comparison to 
the control group. GSH was shown to be a ma-
jor protective agent in oxidative injury by partic-
ipating in the cellular system of defence against 
oxidative damage [13]. It was reported that GSH 
scavenges O2. and protects protein thiol groups 
from oxidation. GSH’s role in restoring other 
free radical scavengers and artioxidants, such 
as vitamin E and ascorbic acid, to their reduced 
state was also investigated [14]. It was reported 
that tissue GSH levels and the activities of glu-
tathione reductase and glutathione peroxidase, 
which are critical constituents of the GSH redox 
cycle, were signiﬁ cantly reduced due to oxidative 
stress, and we propose that impairment of anti-
oxidant defence mechanisms could permit en-
hanced free radical induced tissue damage [15]. 
In the present experiment, the decrease in spinal 
cord GSH concentration after irradiation can be 
explained by the interaction of this enzyme with 
free radicals induced by radiation.
Tissue level of malodialdehyde (MDA) is an in-
dex of lipid peroxidation [15]. It was recently 
shown that administration of melatonin before 
irradiation reduced MDA levels in rat liver [16]. 
Melatonin treatment may also prevent the tissues 
from morphometric damage such as that report-
ed for seminiferous tubules and Leydig cells in 
rats [17]. The present study showed an increase 
in MDA after irradiation; however, the elevation 
of MDA level in the spinal cord may be signiﬁ -
cantly controlled by melatonin treatment. The 
MDA change shows a direct relationship with 
histopathological effects of radiation.
Total protein concentration was found to be re-
duced in vitro after whole body irradiation plus 
melatonin in comparison to the radiation group. 
The contribution of the immune system to de-
fence against oxidative stress may not be a direct 
one [4]. On the other hand, the efﬁ ciency of the 
immune system improves the function of the oth-
er systems and functions in healthy tissues and 
the relation between antioxidant agents and tis-
sue immune system is well known [4]. A positive 
correlation was demonstrated in our results be-
tween the antioxidant capacity and melatonin con-
tents of the irradiated samples. So, supplement-
ing the irradiated tissues with melatonin may have 
some beneﬁ ts to overcome the serious damage 
with further emphasis on radiotherapy patients. 
Compared with radiotherapy alone, administra-
tion of melatonin in combination with radiation 
therapy for untreatable glioblastoma was shown 
to increase the survival rate with a concomitant 
reduction in radiation-induced toxicity [19].
CONCLUSIONS
Due to the antioxidative and free radical scav-
enging properties of melatonin, we suggest that 
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it is able to reduce irradiation-induced toxicities 
in cervical spinal cord. Moreover, it was shown 
that melatonin has the potential to reduce MDA 
levels and also regulate GSH concentration af-
ter irradiation. Therefore, the results of this 
study suggest that melatonin therapy could po-
tentially be an ameliorating agent to reduce ra-
diation effects due to free radicals in the spinal 
cord when it exists as a normal tissue in the irra-
diated volume.
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